Alnylam Pharmaceuticals
ALNY
#638
Rank
S$43.27 B
Marketcap
$335.51
Share price
-1.30%
Change (1 day)
45.53%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) Fails to deliver data

Key failure to deliver metrics for Alnylam Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Alnylam Pharmaceuticals (ALNY) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Alnylam Pharmaceuticals (ALNY) - since 2013

Volume in USD (price x number of shares), data since 2013

Alnylam Pharmaceuticals (ALNY) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024S$38.35 M-26.23%
2023S$51.99 M-66.55%
2022S$0.15 B200.46%
2021S$51.74 M-9.83%
2020S$57.38 M52.34%
2019S$37.66 M46.52%
2018S$25.7 M-70.97%
2017S$88.54 M191.96%
2016S$30.32 M-14.94%
2015S$35.65 M68.07%
2014S$21.21 M152.1%
2013S$8.41 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
S$0.56 MS$9.79 M๐Ÿ‡บ๐Ÿ‡ธ USA
S$14.82 MS$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
S$6.13 MS$39.44 M๐Ÿ‡บ๐Ÿ‡ธ USA
S$5.73 MS$64.27 M๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.85 MS$6.39 M๐Ÿ‡บ๐Ÿ‡ธ USA
S$89.33 MS$0.14 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$11.2 MS$72.21 M๐Ÿ‡ซ๐Ÿ‡ท France
S$17.26 MS$41.19 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel